Benign prostatic hyperplasia (BPH) is a histopathological diagnosis characterized by epithelial cell & smooth muscle cell proliferation in the transition zone of the prostate leading to a non-malignant enlargement of the gland, which may result in lower urinary tract symptoms, including voiding and storage symptoms.
It is commonly called enlarged prostate.
Etiology is unknown but due to its similarity to the embryonic morphogenesis of the prostate has led to the hypothesis that BPH may be the result of "reawakening" in adulthood of embryonic induction processes.
Benign%20prostatic%20hyperplasia Signs and Symptoms
Histopathological diagnosis characterized by epithelial cell and smooth muscle proliferation in the transition zone of the prostate leading to a non-malignant enlargement of the gland, which may result in lower urinary tract symptoms (LUTS), including voiding and storage symptoms
Common disease of aging men
Two phases where prostate doubles its size:
25 years old and beyond
The exact cause of benign prostatic hyperplasia (BPH) is still not well understood
Signs and Symptoms
Dribbling at the end of urination
Pain after ejaculation or urination
Weak or interrupted urine stream
Trouble starting a urine stream
Urine with unusual smell or color
Age 40 years old and older
Family history of benign prostatic hyperplasia (BPH)
Medical conditions such as obesity, heart and circulatory disease, type 2 diabetes mellitus (DM)
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.